LetermovirLack of efficacy and off-label use : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2019卷 / 1期

关键词：

D O I：

10.1007/s40278-024-64155-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[11] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1883 (1) : 45 - 45
[12] FavipiravirLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 175 - 175
[13] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 44 - 44
[14] AlectinibLack of efficacy and off-label use: case report
Reactions Weekly, 2024, 2032 (1) : 25 - 25
[15] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1906 (1) : 166 - 166
[16] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1871 (1) : 52 - 52
[17] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1895 (1) : 165 - 165
[18] SertralineLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1938 (1) : 1156 - 1156
[19] MethylprednisoloneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 275 - 275
[20] OsimertinibLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1949 (1) : 349 - 349

← 1 2 3 4 5 →